ARTICLE | Company News
Link Health, Wilex deal
April 7, 2014 7:00 AM UTC
Wilex granted Link Health exclusive rights to develop and commercialize Mesupron in Taiwan and China, including Hong Kong and Macau, for all cancer indications. Wilex is eligible for an upfront payme...